What is SpectrumAI?
SpectrumAI is at the forefront of revolutionizing behavioral health through artificial intelligence. The company develops sophisticated AI-powered software tailored for Applied Behavior Analysis (ABA) and broader behavioral health providers. Its core offerings focus on delivering data-driven clinical decision support, integrated Electronic Health Record (EHR) functionality, and advanced analytics. By leveraging these tools, therapy organizations can significantly enhance patient outcomes, streamline operational efficiency, and elevate the overall quality of care delivered. SpectrumAI's commitment to technological advancement positions it as a key innovator in the digital health landscape.
How much funding has SpectrumAI raised?
SpectrumAI has raised a total of $29M across 2 funding rounds:
Angel/Seed
$9M
Series A
$20M
Angel/Seed (2022): $9M with participation from F-Prime Capital Partners, Frist Cressey Ventures, and The Autism Impact Fund
Series A (2023): $20M led by Cobalt Ventures
Key Investors in SpectrumAI
Cobalt Ventures
Cobalt Ventures, the venture capital arm of Blue Cross and Blue Shield of Kansas City, focuses on high-growth companies that align with its mission to scale nationally across the payer industry and bring innovative solutions to healthcare that improve outcomes and lower costs.
F-Prime Capital Partners
F-Prime Capital Partners is an investment firm dedicated to backing companies at the intersection of healthcare and technology, leveraging a team of investors, engineers, doctors, and scientists to drive innovation.
Frist Cressey Ventures
Frist Cressey Ventures is a venture capital firm committed to accelerating the growth of transformative healthcare companies, providing capital and strategic support to improve care access, reduce administrative burdens, and enhance patient outcomes.
What's next for SpectrumAI?
With its recent major strategic investment, SpectrumAI is poised for accelerated growth and market penetration. The infusion of capital is anticipated to bolster its research and development efforts, enabling the company to further refine its AI algorithms and expand its suite of data-driven clinical support tools. Strategic partnerships and market expansion are likely next steps, as SpectrumAI aims to solidify its position as a leader in AI-driven behavioral health solutions. The company's focus on improving care quality and operational efficiency for providers suggests a trajectory aimed at addressing critical needs within the healthcare system.
See full SpectrumAI company page
